CYTOKINETICS INC — Director's Dealing 2019

Jan 4, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2019-01-02

Reporting Person: SMITH SANDFORD D (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-01-02	Non-Qualified Stock Option (right to buy)	$6.82	A	3207	Acquired	2029-01-02	Common Stock (3207)	Direct

Footnotes

F1: This option shall vest and become exercisable in 12 equal monthly installments and shall become fully vested on January 2, 2020.